Literature DB >> 7542284

Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.

L A Danielson1, K P Conrad.   

Abstract

Because the kidneys are vasodilated and the endogenous production of nitric oxide is increased in gravid rats, we tested whether nitric oxide mediates the renal vasodilatory response to pregnancy. Chronically instrumented, conscious rats of gestational days 12-14 were studied concurrently with age-matched virgin control animals. GFR and effective renal plasma flow (ERPF) were determined by the renal clearances of inulin and para-aminohippurate before and during acute infusion of N omega-nitro-L-arginine methyl ester (NAME; 2, 20, and 50 micrograms/min) or NG-monomethyl-L-arginine (100 micrograms/min). Baseline GFR and ERPF were significantly increased, and effective renal vascular resistance was decreased by 30-40% in gravid rats compared with virgin controls. During infusion of all three dosages of NAME and NG-monomethyl-L-arginine, effective renal vascular resistance, GFR, and ERPF were equalized in the pregnant and virgin rats (the only exception being GFR during the 20 micrograms/min NAME infusion). When compared with virgin rats, the gravid animals were more responsive to nitric oxide synthase inhibition, showing a significantly greater decline in GFR and ERPF and rise in effective renal vascular resistance at each timepoint during the infusion of inhibitor. To exclude the possibility that nonspecific renal vasoconstriction per se led to equalization of renal function in the two groups of rats, we investigated angiotensin II. In contrast to the results observed with nitric oxide synthase inhibitors, pregnant rats were less responsive to the renal vasoconstrictory effects of angiotensin II, such that the baseline differences in renal parameters measured before infusion of the hormone were increased during the infusion. To determine whether nitric oxide synthase was inhibited to a similar extent in gravid and virgin rats, aortic and renal cortical cGMP content was assayed ex vivo at the end of inhibitor infusion. The lower 2-micrograms/min dose of NAME consistently reduced cGMP content of these tissues to comparable levels in the two groups of rats. In conclusion, we suggest that nitric oxide mediates reduced renal vascular resistance and hyperfiltration during pregnancy in conscious rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542284      PMCID: PMC185222          DOI: 10.1172/JCI118059

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  [A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics].

Authors:  J FUHR; J KACZMARCZYK; C D KRUTTGEN
Journal:  Klin Wochenschr       Date:  1955-08-01

2.  Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney.

Authors:  C Baylis; P Harton; K Engels
Journal:  J Am Soc Nephrol       Date:  1990-12       Impact factor: 10.121

3.  Influence of oxytocin on renal hemodynamics and electrolyte and water excretion.

Authors:  K P Conrad; M Gellai; W G North; H Valtin
Journal:  Am J Physiol       Date:  1986-08

4.  Effects of progesterone and estrogen on the sensitivity to angiotensin II.

Authors:  L C Chesley; I H Tepper
Journal:  J Clin Endocrinol Metab       Date:  1967-04       Impact factor: 5.958

5.  Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats.

Authors:  M Gellai; J H Silverstein; J C Hwang; F T LaRochelle; H Valtin
Journal:  Am J Physiol       Date:  1984-06

6.  Identification of increased nitric oxide biosynthesis during pregnancy in rats.

Authors:  K P Conrad; G M Joffe; H Kruszyna; R Kruszyna; L G Rochelle; R P Smith; J E Chavez; M D Mosher
Journal:  FASEB J       Date:  1993-04-01       Impact factor: 5.191

7.  Glomerular ultrafiltration in the pseudopregnant rat.

Authors:  C Baylis
Journal:  Am J Physiol       Date:  1982-09

8.  Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats.

Authors:  K P Conrad; M C Colpoys
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 9.  Nitric oxide in the kidney: synthesis, localization, and function.

Authors:  S Bachmann; P Mundel
Journal:  Am J Kidney Dis       Date:  1994-07       Impact factor: 8.860

10.  Prostaglandin E2, plasma renin activity, and renal function throughout rabbit pregnancy.

Authors:  R C Venuto; A J Donker
Journal:  J Lab Clin Med       Date:  1982-02
View more
  37 in total

1.  Relaxin is a potent renal vasodilator in conscious rats.

Authors:  L A Danielson; O D Sherwood; K P Conrad
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Relaxin is essential for renal vasodilation during pregnancy in conscious rats.

Authors:  J Novak; L A Danielson; L J Kerchner; O D Sherwood; R J Ramirez; P A Moalli; K P Conrad
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Impact of pregnancy on underlying renal disease.

Authors:  Chris Baylis
Journal:  Adv Ren Replace Ther       Date:  2003-01

Review 4.  Effects of relaxin on arterial dilation, remodeling, and mechanical properties.

Authors:  Kirk P Conrad; Sanjeev G Shroff
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

5.  The renal adaptation to pregnancy is now "NOS"-talgic.

Authors:  J G Umans; M Lindheimer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 6.  The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system.

Authors:  Crystal A West; Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-05

Review 7.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat.

Authors:  Xi-Ping Ni; Massy Safai; Rahul Rishi; Chris Baylis; Michael H Humphreys
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

Review 9.  Relaxin, a pleiotropic vasodilator for the treatment of heart failure.

Authors:  Sam L Teichman; Elaine Unemori; Thomas Dschietzig; Kirk Conrad; Adriaan A Voors; John R Teerlink; G Michael Felker; Marco Metra; Gad Cotter
Journal:  Heart Fail Rev       Date:  2008-12-20       Impact factor: 4.214

10.  Receptor-induced dilatation in the systemic and intrarenal adaptation to pregnancy in rats.

Authors:  Vanessa M Ferreira; Thiago S Gomes; Luciana A Reis; Alice T Ferreira; Clara V Razvickas; Nestor Schor; Mirian A Boim
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.